CA
NZ
UK
AU
IND
US
Management said the OPUS-1 trial enrolled 3,572 adults aged 50 and older, plus 475 adults aged 18 to 49, and compared VAX-31 head to head with PCV20 and PCV21. The company reported that VAX-31 met all prespecified primary endpoints. All 28 serotypes shared with …
The company stated that the majority of its future revenues for the foreseeable future come from Papzimeos sales as commercial activities expand. It said its transition to sustained profitability depends on continued commercialization of Papzimeos and potential commercialization of other candidates. It reported profitability …
The company had 607 fertility and family building clients at September 30, 2026, against 553 a year earlier. Average members were 7,176,000 in the quarter, against 6,757,000. Management said the majority of the new clients and lives are stated to go live in the …
Operating income was USD 38 million, against USD 59 million, aMarginof 6.4% against 9.7%. Adjusted EBITDA was USD 135 million, up 4.0% from USD 130 million, and Adjusted FFO attributable to stockholders was USD 79 million, against USD 70 million. Diluted Adjusted FFO per …
Chairman and Chief Executive Matthew V. Crawford said the global industrial economy, led by North America, continues to support the company, and that demand has been ahead of plan throughout the year. He pointed to semiconductor, electrical infrastructure and aerospace and defense, and said …
The full year range is stated for adjusted net income, a non-GAAP measure, and the company did not provide a reconciliation to GAAP net income, citing items it cannot predict. The Board declared a quarterlyCash Dividendof USD 0.45 per share on October 29, 2026, …
Segment revenue for home health and hospice was USD 239.81 million against USD 173.55 million, with segment adjusted EBITDAR from operations of USD 41.37 million against USD 29.07 million. Total home health admissions were 28,479 against 20,426, including 11,347Medicareadmissions against 8,221. Average Medicare revenue …
GAAP operating expenses are guided to USD 53.0 million to USD 54.0 million, and non-GAAP operating expenses to USD 42.5 million to USD 43.5 million. GAAPOperating Marginis guided to 10.0% to 12.0%, while non-GAAP operating margin is guided to 19.0% to 21.0%.
Revenue rose 20%, which the company attributed to onboarding of new customers andVolumeacross the existing base. Revenue from existing customers was USD 26.1 million, up 21%, while revenue from new customers was USD 1.6 million, up 11%. Customers with pricing contracts accounted for 78% …
Total production was 457.5 MBoe/d, which the company said was 22% above the prior quarter. Oil was up 5%, NGLs up 37% at 118.3 MBbls/d andNatural Gasup 42% at 787.1 MMcf/d.
Please wait processing your request...